Active ingredients:Drostanolone Propionate Pharmacological category:Anabolic Steroid Composition:Every 1 ml contains 100 mg of Drostanolone Propionate in Ethyl oleate Mechanism of medicine action: Drostanolonum Propionate, when injected, provides a peak release of the base steroid about one day after injection. Drostanolonum acts similarly to testosterone, although has proven safer with users as it is not metabolized by aromatase or 5a-reductase into estrogenic compounds such as estradiol, or into DHT. It does also carry a more favorable balance towards anabolism than androgenism. This also means that it does not cause the high water retention normally associated with highly androgenic steroidal compounds like methandrostenolone. Once metabolized, the drug has the effect of increasing nitrogen uptake by muscle, leading to an increasing in the rate of protein synthesis. It also has the secondary effects of stimulating appetite, reducing the amount of fat being deposited in the body, and decreasing the rate of catabolism. Drostanolonum Propionate has a half of 2-3 days. Indications: Males: Drostanolonum is indicated for increasing muscular mass, hardness and strength without water retention and now estrogenic activity, as well as increasing the metabolic rate, which means an increase of the fat burning rate. Famales: Drostanolonum may be used secondarily in postmenopausal women with advancing inoperable breast cancer. Contradictions: Drostanolonum is contradicted in men with carcinomas of the breast or with known or suspected carcinomas of the prostate or liver/renal diease. Also in anyone with hypersensitivity to the drug or any of its excipients. Precautions: Drostanolonum, through its metabolic effects, stimulates the nervous, mental, and physical activities of a patient. Therefore, it should be used with caution in the presence of cardiovascular and renal diseases, especially in the elderly male. Prolonged administration or excessive dosage may cause inhibition of testicular function. As a result, oligospermia may develop, and there may be a decrease in ejaculatory volume. Women should be observed for signs of virilization. Discontinuation of drug therapy at the mild virilism becomes evident is necessary to prevent irreversible virilization. Such virilization usually follows administration of androgens at high doses.A decision may be made by the patient and the physician concerning the degree of virilization that will be toleranted during treatment for breast carcinoma. Anaphylactoid reactions, although rare, may occur, and treatment should be readily available. Hypersensitivity reactions, including rash and dermatitis, have been reported. Women should be observed for signs of virilization. Discontinuation of drug therapy at the mild virilism becomes evident is necessary to prevent irreversible virilization. Such virilization usually follows administration of androgens at high doses. A decision may be made by the patient and the physician concerning the degree of virilization that will be toleranted during treatment for breast carcinoma. Anaphylactoid reactions, although rare, may occur, and treatment should be readily available. Hypersensitivity reactions, including rash and dermatitis, have been reported. Drug interactions: In diabetic patients, the metabolic effects of nandrolone may decrease blood glucose and insulin requirements. Dosage: Drostanolonum propionate is administrated by intramuscular injection. It must not be given intravenously. Intramuscular injections should be given deep in the gluteal muscle. Males: 200-400 mg per week, given 2-3 times weekly. Females: for breast cancer treatment 200-300 mg per week, given 2-3 times weekly. For physique or performance enhancing purposes 50-75 mg per week, given 2-3 times weekly. Storage: Store in a dark, dry place, at room temperature. Do not refrigerate. Keep out of reach of children. Manufactured by: Bulgarian Pharma Ltd.